|
Small Molecule Potentiators for Treatment of Central Nervous System Disorders
Application
Series of compounds for selectively potentiating N-methyl-D-aspartate (NMDA) receptor subunit NR2C for treating central nervous system impairment.
Key Benefits
Selectivity for NR2C may reduce possibility of adverse side effects.
Market Summary
N-methyl-D-aspartate (NMDA) receptors are widely dispersed in the central nervous system...
Published: 7/28/2023
Contributor(s): Stephen Traynelis, Praseeda Mullasseril, Ethel Garnier-Amblard, Dennis Liotta, Sommer Zimmerman
|